Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma
=====================================================================================================================

* Arun Rajan
* Christopher R. Heery
* Anish Thomas
* Andrew L. Mammen
* Susan Perry
* Geraldine O’Sullivan Coyne
* Udayan Guha
* Arlene Berman
* Eva Szabo
* Ravi A. Madan
* Leomar Y. Ballester
* Stefania Pittaluga
* Renee N. Donahue
* Yo-Ting Tsai
* Lauren M. Lepone
* Kevin Chin
* Fiona Ginty
* Anup Sood
* Stephen M. Hewitt
* Jeffrey Schlom
* Raffit Hassan
* James L. Gulley